HiRO Leads Cross‑Border Dialogue at JPM, Offering Insights for Biotechs Seeking Asian Investment

Summary

HiRO, a contract research organization, participated in JPM conference to discuss cross-border clinical trial solutions and Asian investment opportunities for biotechs. No material business developments, financial results, or clinical data disclosed.